Debiopharm, Nobelex to develop new antibiotics for N. Gonorrhoeae and Enteric Species
The two programs, which issue from Affinium’s FabI discovery platform acquired by Debiopharm in February 2014, will lead to the development of narrow-spectrum antibiotics. As part of the